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During early heart development, Tbx2 gene expression is initiated
in the cardiac crescent and then becomes restricted to the outflow
tract and the atrioventricular region. We identified a Tbx2 regu-
latory region, enriched in multiple Smad sites, sufficient to repro-
duce Tbx2 expression patterns overlapping Bmp2 and Bmp4 gene
activity in the heart. The role of Tbx2 in cardiogenesiswas analyzed
by using Cre-LoxP activated Tbx2 transgenic misexpression in
chamber myocardium. Ventricular Tbx2 misexpression exhibited
an abnormally narrow chamber lumen owing to the expansion of
Hyaluronan synthase 2 expression in the ECM or cardiac jelly and
the appearance of the endocardial cushions (ECs). Excessive Tbx2
also induced Tgf2, which coincidedwith the outgrowth epithelial-
mesenchymal transformed cells in ventricular and atrial tissues
modifying cardiomyocyte identity from chamber type to non-
chamber type. Tbx2, a central intermediary of Bmp-Smad signaling,
has a central part in directing Has2 and Tgf2 expression, facili-
tating EC formation.
cardiac jelly  cardiomyocyte identity 
epithelial-mesenchymal transformation  extracellular matrix 
misexpression
The heart develops, as a modular organ, driven by distincttranscriptional regulatory programs that control each ana-
tomical region (1). A member of the T-box factor family, Tbx2,
which first appears in the cardiac crescent and then later
restricted to non-chamber myocardium (My) [outflow tract
(OFT), atrioventricular canal (AVC), inner curvature, and in-
flow tract) (2, 3)], is a valuable model of modular cardiac gene
activity. Tbx2 is central for endocardial cushion (EC) formation
and chamber specification, and may be a transcriptional repres-
sor (4, 5). Expression of chamber-specific myocardial genes,
which include Nppa (encoding atrial natriuretic factor, ANF),
Gja5 (encoding connexin 40, Cx40), and Gja1 (encoding con-
nexin 43, Cx43), were repressed by Tbx2 (3–5). Tbx2 null mutant
embryos exhibited small AVC and defective OFT septation (3),
whereas Tbx2 transgenic expression blocked chamber formation
(4) and cell proliferation in the OFT and AVC (6).
The ECs form from localized expansion of the ECM also
named cardiac jelly (7, 8) found in the cardiac OFT and AVC
segments the simple heart tube into a complicated structure
composed of the aortic sac, common ventricular chamber, and
atrial chamber. Some endocardial cells invade into the ECM
through epithelial-mesenchymal transformation (EMT) to re-
model the cushion tissue into themature valves. Several signaling
pathways have been implicated in EC formation. The Bmp
pathway is essential for both processes; expansion of ECM and
EMT in the EC formation (9–14). Tgf2 performs crucial and
sequential roles in EC formation and may also be regulated by
Bmp2/4 during cardiogenesis (9–11). The hyaluronan (HA)
synthase 2 (Has2) has been recently shown to have essential role
in expansion of ECM and EMT (16). Also, Tbx2 may be a direct
target of Bmp2/4 signaling pathway during EC formation (2).
Here, we delineated an 80-bp regulatory region within the
Tbx2 5 f lanking sequences, which contain multiple Smad DNA
binding sites that recapitulate expression of Tbx2 in the AVC and
OFT. Previously, myocardial-specific inactivation of Bmp2 also
inhibited the appearance of several factors, including Tbx2,
Tgf2, and Has2, and blocked cushion formation (9). To define
the regulatory hierarchy shared by Bmp2/4-dependent genes, we
analyzed embryos in which murine Tbx2 was misexpressed in the
developing chamber My, using a mouse genetic system based on
Cre/loxP recombination. Tbx2 altered cardiogenic lineage spec-
ification by expanding the ECM and EMT to drive EC formation
via the induction of Tgf2 and Has2 gene activity in embryonic
hearts.
Results
Smad Signaling Drives Tbx2 Transgene Activity via a Distal Enhancer.
Tbx2 expression was first detected in the cardiac crescent and
notochordal plate (Fig. 1A). At E8.5, Tbx2 expression was
maintained only in the posterior portion of the looping heart
(Fig. 1B). As the heart matured, the expression of Tbx2 became
further limited to the AVC and OFT region (Fig. 1 E and F).
Tbx2 mRNA was also detected in the optic cups, otic vesicles,
pharyngeal arches, and limb buds of embryonic day (E)9.5 and
E10.5 mouse embryos (Fig. 1 C and D). Transient F0 transgenic
mice harboring 4.1 kilobase (kb) of Tbx2 5 f lanking sequences
linked to the lacZ reporter gene (Fig. 1K) revealed -galacto-
sidase activity in the OFT, AVC, and a portion of the left atrium,
whereas LacZ activity was absent from the right atrium and the
ventricles (Fig. 1L). Also, Tbx2, a downstream target of murine
Bmp2/4 signaling (2, 9), was colocalized to the AVC and OFT
(Fig. 1 G–J). After serial and gap deletion mutagenesis strategy,
recapitulated Tbx2 expression was delineated to a region be-
tween 3.4 and 2.6 kb in transgenic mouse embryos (Fig. 1
L–O).
Paired Smad 1/4 proteins, primary intracellular mediators of
Bmp signals (12), activated transcription of the4.1-kb reporter
construct (Fig. 2A). Other Smad factor combinations did not
strongly activate the Tbx2 reporter, whereas the inhibitory Smad
6 (13, 14) blocked Tbx2 gene activity. Tbx2 regulatory region
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responsive to Bmp signaling was localized to a 290-bp region
expression in the developing heart (Fig. 2 B and C), which
contains at least five conserved Smad sites, two of which, SBE1
and SBE5 sequences, were potent Smad1/4 cofactor binding sites
(Fig. S1). Schematic representation of Tbx2 transgenes analyzed
in E9.5 F0 embryos and a summary of the tissue restricted
expression activity is shown in Fig. 2C, whereas five SMAD sites
in SBE1-5 were mutated by site directed mutagenesis as shown
in mSBE1-5 (Fig. 2D). The gap deletion mutant 2899/2602
hsp68lacZ construction, in which the five Smad sites were
removed from the Tbx2 5 f lanking sequence, showed a complete
loss of lacZ expression activity in the hearts of F0 transgenic
embryos (Fig. 2 C and F). The Smad site enriched region (SBE;
2916/2602) linked to a minimal hsp68 promoter lacZ trans-
gene, revealed robust expression in the OFT and AVC, sufficient
to recapitulate the restricted Tbx2 expression pattern in the heart
(Fig. 2 C and G), whereas site directed Smad site mutations
eliminated gene activity in transgenic mice (Fig. 2 C and H).
Abnormal Deposition of ECM in mTbx2-Misexpressing Embryonic
Hearts. To study the role of Tbx2 in the cardiac morphogenesis,
we generated transgenic mice that conditionally misexpressed
murine Tbx2 gene in embryonic chamber-cardiomyocytes (Fig.
3 A and B; Fig. S2). Activated Tbx2 embryos exhibited enlarged
hearts, with marked myocardial hypoplasia associated with rich
deposition of ECM in the compact and trabecular My (Fig. 3 C
and D). Expansion of the EC (cardiac jelly) between the
endocardium (En) and My (Fig. 3E) stained with alcian blue for
acidic glycosaminoglycans (15) caused a narrow ventricular
lumen. In control littermates, acidic glycosaminoglycans were
deposited mainly in the ECM of OFT and AVC regions at E10.5
compared with the expanded ECM induced by activated Tbx2.
Glycosaminoglycan HA, a major constituent of the cardiac
jelly, may be required for the expansion of EC (16,17). Excessive
acidic glycosaminoglycans deposited through the cardiac tube in
mTbx2-misexpressing embryos were also revealed by deposition
of HA with the biotinylated-HA binding protein (BP; Fig. 3F).
The specific binding of HABP to HA was eliminated by hyal-
uronidase treatment (Fig. S3). HA deposition was observed
between the En and My in the inner curvature and the AVC of
both control littermates and mTbx2-misexpressed mice, and in
between the En and My of the outer curvature of mTbx2-
misexpressed ventricles (Fig. 3F). Also, cultured cardiomyocytes
from quartered hearts identified by lacZ and or byMyh6 induced
mTbx2 expression (Fig. 3G; Fig. S4) were classified by the
amount of HA secretion (Fig. 3H). Tbx2-misexpressing ventric-
ular myocytes secreted greater amount of HA compared with
ventricular myocytes from control littermates.
Has2 and Tgf2 are Tbx2 Downstream Gene Targets. Is there a
hierarchical relationship between Tbx2, Has2, and Tgf2? HA
synthatase (Has)2, the major enzyme responsible for HA syn-
thesis in the AVC and atria, was strongly up-regulated in the
ventricular My by mTbx2 misexpression (Fig. 4). In comparison,
other components of the ECM, including Col1a1 (encoding type
I collagen), Cspg2 (encoding chondroitin sulfate proteoglycan 2,
versican), Fn1 (encoding fibronectin 1), and Tnc (encoding
tenascin C) did not show obvious differences (data not shown).
Has2 is a direct Tbx2 target, because T-box binding sites were
conserved between Has2 promoter regions, which recruited en-
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Fig. 1. Mouse Tbx2 gene activity in early cardiac development was recapitulated by distal cis-acting regulatory regions coincided with Bmp2 and Bmp4 expression.
Tbx2 expression was first detected in the cardiac crescent at E7.5 (A), and restricted to the posterior part of looping heart at E8.5 (B). The expression of Tbx2was also
observed in the developing eye, otic cup, pharyngeal arches, and limb buds (B–D) At E9.5 and E10.5, Tbx2 transcripts were localized in the OFT and AVC (E and F). .
Expression ofBmp2 andBmp4 (G andH) was observed in theOFT andAVC (I and J). Schematic representation of serial deleted 5flanking sequences of the Tbx2 gene,
which were analyzed for transgene expression patterns in E9.5–E10.5 F0 founder embryos (K). An upstream regulatory region that directs Tbx2 gene expression was
indicated by a red bar. LacZwas expressed in the optic cup, heart, and pharyngeal arches using 4.1 kb (L), 3.4 kb (M), and 2602/234 (N) 5 flanking fragments. No
LacZ staining was observed in2.6-kbZ transgenic embryos (O). Cc, cardiac crescent; Ht, heart; LA, left atrium; Lb, limb bud; LV, left ventricle; OC; optic cup; Ot, otic
cup; PA, pharyngeal arch. Restriction sites shown above are: Nh, NheI; Xh, XhoI; Av, AvrII; Xb, XbaI; and Ba, BamHI.
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dogenous Tbx2 from cardiac nuclear chromatin extracts and was
transactivated by Tbx2 (SI Materials and Methods and Fig. S5).
Tgf2 is normally expressed in the myocardial cells in the OFT
and AVC, but was induced by Myh6-Cre activated mTbx2 in
ventricular and atrial My (Fig. 5 A and B). Also, phosphorylated
Smad2 appeared in the endocardial and myocardial cells of
mTbx2-activated ventricles and atria (Fig. 5C), which coincided
with robust in vitro EMT assays (Fig. 5D andE); thus, suggesting
that the Tgf2 signaling pathway was activated by mTbx2. Tgf2
may also be a direct target of Tbx2, because the Tgf2 promoter
has conserved T-box binding sites, bound endogenous Tbx2, and
was activated with a Tbx2-expression vector (SI Materials and
Methods and Fig. S6).
Discussion
Smad Factor Signaling Directed Tbx2 Expression Through a Distal
Enhancer During Early Murine Cardiogenesis. Tbx2 transcripts first
appear in the cardiac crescent and then later became restricted
to the OFT and AVC during early avian (2) and mouse embry-
ogenesis (Fig. 1). Tbx2 is also expressed in the embryonic limb,
optic cup, otic cup, and pharyngeal arches. Approximately 4 kb
of 5 f lanking sequence of the murine Tbx2 gene was sufficient
to reproduce much of these mouse embryonic expression pat-
terns, as a lacZ reporter transgene. LacZ expression patterns
closely overlapped with those ofBmp2 andBmp4 in the heart and
eye, and was delineated within the Tbx2 5 f lanking sequences,
which contained Bmp directed multiple high-affinity binding
sites for Smad transcription factors. Removal of these multiple
Smad sites by gap deletion mutagenesis from the 4-kb flanking
sequences blocked reporter gene activity in early embryos. In
contrast, this short enhancer region linked to a minimal hsp68
promoter was sufficient for steering the restricted expression of
lacZ in a pattern, highly similar to the endogenous Tbx2 gene
activity. Previously, application of Bmp2 selectively induced
cTbx2 expression in noncardiogenic embryonic tissue, and the
Bmp antagonist Noggin down-regulated cTbx2 activity (2). Also,
the appearance of murine Tbx2 was blocked in Bmp2 null mouse
embryos (2). Thus, Tbx2 expression depended on Bmp signaling
through Smad factors, a regulatory paradigm that also guides
other modular-restricted genes in the developing heart.
Tbx2 Directs EC Formation. Tbx2 is generally considered to be a
transcriptional repressor. For example, Tbx2-null embryos have
expanded chamber-specific gene expression into the AVC My
(3). Also, Tbx2-overexpressing transgenic mice and Tbx20-null
mice, in which Tbx2 is up-regulated, exhibited decreased expres-
sion of several chamber-specific genes and caused hypoplasia of
ventricular chamber (4–6, 18, 19). However, Tbx2 also contains
an activation domain (20), and is important for EC formation,
because Tbx2 null mutant embryos exhibited small AVC and
defective OFT septation (3). As shown here, Tbx2 enhanced
ECM synthesis from myocardial cells and EMT from endocar-
dial cells. Tbx2 directly bound Has2 and Tgf2 promoters and
increased their transcriptional activities. Tgf signaling is crucial
Fig. 2. Delineation of the distal Smad factor dependent Tbx2 enhancer. (A) Multiple Smad expression vectors tranfected into CV1 cells revealed activation
caused by Smad1/4 of the 4.1 kb of 5 flanking sequence of Tbx2 fused in-frame to the luciferase. The bars represent the average of three independent
transfections, and the error bars represent the SE of corrected luciferase activity relative to the pCMV5 control vector. (B) Activation by Smad1/4 required the
2889/2602 region. (C) Schematic representation of Tbx2 transgenes analyzed in E9.5 F0 embryos and a summary of the tissue restricted expression activity.
(D) Five SMAD sites in SBE1-5weremutatedby site directedmutagenesis inmSBE1-5. (E–J) LacZ expressionpatterns in E9.5 F0 embryos. (E)3253/28682hsp68Z
transgene; a gap deletion mutant, of a region immediately upstream of the multiSmad sites. (F) 2899/2602hsp68lacZ; a gap deletion mutant in which the
multiple Smad sites were removed from the 5 flanking sequence. (G) SBE(2916/2602)hsp68lacZ; the region from 2916 to 2602bp, containing five Smad
sites, was linked to the hsp68lacZ reporter gene. (H) mSBE(2916/2602)hsp68lacZ; mutations were inserted at the multiple Smad sites in the 2916/2602
fragment. LacZ expression were recapitulated by the DNA fragments containing Smad binding sites (E and G), whereas gap deletion and point mutagenesis of
Smad binding sites eliminated gene activity in transgenic mice (F and H). Restriction sites are: BlpI; Xh, XhoI.
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for EMT in the AV cushions (20–22). Accelerated appearance
of EMT from the ventricular and atrial tissues, in vitro EMT
assays and increased Smad2 phosphorylation inmTbx2-activated
embryos supports activation of Tgf2 pathway by Tbx2.
Tbx2 also induced Has2 myocardial expression and increased
HA deposition. HA is known as an essential factor for EC
formation (8, 16, 23), and interacts with other molecules such as
versican and fibrillin, which expands cardiac jelly providing
extracellular space for cell migration (8). In addition to orga-
nizing extracellular environment, HA stimulates EMT of several
types of epithelial cells (24) and endocardial cells dependent on
Ras-activation (15) via ErbB2 receptor (23). In Tbx2-
misexpressing embryos, extradeposition of HA was observed in
the dilated chamber My; thus, Tbx2 has an important role in EC
formation by increasing synthesis of HA. During normal heart
development, chamber-cardiomyocytes undergo a critical mat-
uration step that is manifested by a transition from production
to degradation of ECM between E8.0 and E9.5 (25). Whereas
HA is required for cushion formation, excess HA depositionmay
cause hemodynamic alteration and prevent cardiomyocyte dif-
ferentiation necessary for chamber maturation.
Hierarchical Relationship Between Bmp2/4, Tbx2, Has2, and TGF2.
We propose a model in which Bmp-Smad responsive Tbx2 is
stimulated to perform a central role in promoting EC formation
by inducing expansion of ECM and EMT by directing Has2 and
Tgf2 gene activity (Fig. 6). Several signaling pathways have
been implicated in EC formation. The Bmp pathway is essential
for expansion of ECM and EMT in EC formation. Myocardial-
specific inactivation of Bmp2, Bmp4, and a Bmp type I receptor
gene, Alk3, respectively, failed to form the EC (9, 10, 26). Sugi
et al. (11) demonstrated that Bmp2 could substitute for the My
to induce EMT. Also, noggin treatment of explants efficiently
inhibited EMT. In both chicken and mouse EMT assays, Tgf2
is able to replace the overlying My to activate EMT in Tgf2 null
mice (11, 16, 21, 22). Analysis of Tgf2-deficient mice also
indicated that Tgf2 is important for valvulogenesis (27). Recent
studies have shown that several factors, including Tbx2, Tgf2,
and Has2, are downstream targets of Bmp2/4 pathway (9, 10). In
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Fig. 3. Abnormal cardiac morphogenesis induced by
activatedmTbx2 coincidedwithexcessiveHAdeposition.
(A) Schematic representation ofMyh6-Cre induced acti-
vation of mTbx2 by breeding ZmTbx2 mice to the Cre
deletermouse line,Myh6-Cre. (B)Cardiomyocyte-specific
activated mTbx2 was detected by immunoperoxidase
staining in the atria and ventricles at E9.75. (C) Enlarged
images highlight embryonic hearts at E10.5. Relative to
control littermates, activated Tbx2 embryos exhibited an
enlarged heart, which appeared as swollen single ven-
tricular and atrial chambers, and a dilated AVC (yellow
dotted line in C) at E10.5. (D) Histological sections of
activated mTbx2 in embryonic hearts at E9.75 stained
with HE staining showed rounded ventricular chamber
(blue dotted line) and an abnormally narrow ventricular
lumendue toexpansionof EC like structurebetween the
En andMy (two-headed arrow inD), and arrow indicate
intraventricular sulcus (IVS) and arrowheads indicate
AVC. (E)Histological sectionsofembryonichearts stained
at E10.5with alcian blue revealed acidic glycosaminogly-
cans (blue stain) not only deposited in the OFT and AVC
regions of control littermates (black asterisks), but
throughout the chambers of activated Tbx2 hearts (red
asterisks). (F) Visualization of HA on sections of E9.75
embryoswithHABP (red).HAwasdepositedbetweenEn
and My in the inner curvature and AVC of activated
mTbx2 embryos and control littermates (white asterisks)
and not in the outer curvature of control littermates.
ExtradepositionofHAwasobservedbetweenEnandMy
in theouter curvatureofmTbx2-misexpressing ventricles
(yellowasterisks).DAPI stainwasused tovisualizenuclei (blue). (G) VisualizationofHAonculturedventricularmyocytes fromembryosof E9.5or E9.75withHABP (red).
Immunocytochemicaldetectionof lacZandTbx2 (green). (H) PercentageofclassifiedcardiomyocyteswithHAsecretion.Type I cardiomyocytes,nosecretionofHA;Type
II, little amount of HA around the cells; Type III, much HA is secreted around the cells; Type IV, much HA is secreted around the cells and deposited in the cells (Fig. S4).
Majority of ventricular cardiomyocytes secreted excessive HA in the activatedmTbx2 embryos. T, trabeculae; CL, compact layer; and TL, trabecular layer.
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Fig. 4. HA synthetase,Has2, activated by Tbx2 in cardiac chamber myocytes.
(A) Real-time PCR analysis of dissected embryonic hearts at E9.5 or E9.75.Has2
transcripts were tripled in the ventricles of activated mTbx2 embryos. (B)
Whole-mount in situ hybridization analysis for Has2 expression was detected
in the AVC (black arrowheads) of control littermates whereas expanded to
ventricles (red arrowheads) of activated Tbx2 embryos. The middle and right
columns show sections after WISH. Has2 expression was activated in ventric-
ular myocardial cells of activated Tbx2 embryos (right column). Nuclear were
stained by nuclear fast red.
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addition to myocardial-derived Bmp function, Bmp signals di-
rectly to the cushion En through the Bmpr1a to induce EMT (9).
In our experiments, Bmp2/4 were not up-regulated in Tbx2-
misexpressing embryos (Fig. S7). Recently, Singh et al. (28)
showed that Tbx20 directly interfered with Bmp/Smad signaling
to suppress Tbx2 expression in the chambers; thereby, confining
Tbx2 expression to the prospective AVC region. They also
confirmed our observation that Tbx2 distal enhancer directs
Tbx2 expression to the AVC and OFT. Here, we showed
Bmp-Smad signaling dependent Tbx2 expression directed Has2
and Tgf2 gene activity to coordinately regulate EC formation.
Experimental Procedures
Generation of mTbx2 Reporter Gene Constructions. A genomic fragment that
contained the Tbx2 locus was isolated from a 129SVJ mouse genomic library.
A 4.5-kbNotI fragment flanking the 5 transcription start site andoverlapping
the first coding exon was cloned into the NotI site of pBluescript-KS for
sequencing. The mTbx2 reporter construct were generated from 4.1 kb of
mTbx2 flanking sequence 5 was linked in-frame in front of the lacZ and
luciferase cDNA from pPD46.21 and pGL3-Basic (Promega). Deletion con-
structs were generated by restriction endonuclease digestion. The region
from 2916 to 2602bp, containing multiple Smad sites, was linked to the
hsp68lacZ reporter gene (29). Mutations at multiple Smad sites in 2916/
2602 fragmentwere inserted using In-Fusion PCR cloning kit (Clontech) (Fig.
2D; Fig. S1C).
Whole-Mount in Situ Hybridization. Staged mouse embryos were obtained
after timed mating of mice with the morning of the copulation plug being
E0.5. Embryos were fixed in MEMFA (0.1 M Mops/2 mM EGTA/1 mM MgSO4/
3.7% formaldehyde) and stored in 90% methanol at 20 °C until use for
hybridization.Whole-mount in situ hybridizationwas performed as described
by Yamada et al. (2), except that polyvinyl alcohol was included to increase
signal intensity. A full-length ofmTbx2 cDNA (kindly provided by Roni Bollag)
was cloned into the EcoRI site of pBluescript-KS to synthesize digoxigenin-
labeled RNA probes. After restriction endonuclease digestion with SacI, anti-
sense probes were transcribed with RNA labeling kit (Stratagene).
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Fig. 5. Activated mTbx2 induced Tgf2 and enhanced EMT. (A) Real-time PCR analysis of quartered embryonic hearts at E9.5. Tgf2 was increased in the
ventricles and atria of activatedmTbx2heart. (B)Whole-mount in situ hybridization analysis detected Tgf2 expression in theAVC (black arrowheads in controls)
and OFT of control littermates which expanded to ventricles and atria of activated Tbx2 hearts (red arrowheads in misexpressed Tbx2). The middle and right
columns show sections afterWISH. Tgf2 expressionwas activated in ventricularmyocardial cells of activated Tbx2 embryos (right column). Nuclearwere stained
by nuclear fast red. (C) Immunohistochemical detection of phospho-Smad2, an effector of Tgf signaling in the AVC (white arrows) En of control littermates
(white arrowheads), which was expanded to the En of the ventricles and atria in activated mTbx2 hearts (red arrowheads). (D and E) Immunohistochemical
detection of -smooth muscle actin (SMA) showed increased EMT in in vitro collagen gel assays of ventricular and atrial explants. The percentage of anti-SMA
positive cells formed in explants from mTbx2-misexpressing ventricles and atria was approximately doubled compared with controls.
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Fig. 6. Model of Tbx2 function for the EC formation in the AVC. ThemTbx2
misexpression induces expression of Has2; thereby, driving the synthesis and
deposition of HA and/or cardiac jelly through the heart. Misexpressed Tbx2
signals also promotedexpressionof Tgf2gene that supports the inductionof
EMT in the ventricles and atria. In the normal heart development, Tbx2works
as one of the important factor to induce expansion of ECMand EMTunder the
Bmp2/4-Smad signaling pathway. Bmp signals also directly to the En through
the Bmpr1a.
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Transient Transfection Assays.Monkey CV-1 fibroblasts were grown in DMEM
with 10% FBS. Cells were plated at 1 105 cells per well in a 24-well plate and
transfected 24 h later with DNA mixture containing a total of 2 g of total
DNA, which included 500 ng of luciferase reporter vector, 500 ng of -galac-
tosidase vector, and a total of 1 g of pCMV5-derived vectors. Transfections
wereperformedusingLipofectamine (Invitrogen) asdescribed (30). Luciferase
activity were measured using a luminometer to detect activates substrates,
then normalized by -galactosidase activity (29).
Histology. Embryosweredissected inDulbeco’s PBS andfixedovernight at 4 °C
in 4% PFA in PBS for histological analysis. After fixation, embryos were rinsed
in PBS, then dehydrated through graded ethanol ormethanol and embedded
in paraffin wax. Sections were cut and stained with hematoxylin-eosin or
alcianblueaccording to standardmethods. TheHAwasdetectedwith2g/mL
biotinylatedHABP isolated frombovinenasal cartilage (Seikagaku). TheHABP
was detected using streptavidin-conjugated AlexaFluor (Invitrogen). For im-
munohistochemistry, sections were incubated with rabbit anti-TBX2 IgG (Up-
state Biotechnology) or rabbit anti--galactosidase (Biogenesis). Primary an-
tibody was detected with goat anti-rabbit IgG labeled with Alexa Fluor
(Invitrogen).
Real-Time PCR. Embryonic hearts at E9.5–E9.75 were divided to 4-parts, OFT,
ventricles, AVC, atria at the posterior boundary of EC in OFT, anterior and
posterior boundaries of EC. Dissected tissues were immediately frozen in
liquid nitrogen and stored at 80 °C until embryo and yolk sac DNA was
genotyped. Total RNA isolation and first strand cDNA synthesis were per-
formedwith TRIzol reagent, SuperScript III (Invitrogen) and randomprimer, as
per the manufacturer’s instructions.
Primary Culture of Embryonic Cardiac Cells and Classification of Cardiomyocytes
with HA Synthesis. Quartered embryonic cardiac tissues were separated as
described above. After trypsinization, isolated cardiac cells were cultured on
gelatinizeddishes by using culturemediumcontainingDMEM(D5796; Sigma–
Aldrich), 10% heat-inactivated FCS (HyClone), 0.1 g/mL penicillin, and 0.1
mg/mL streptomycin. After 4 days culture, cells were fixed in 4% PFA in PBS
and detected HA, Tbx2 and -galactosidase as described above. Classification
of cardiomyocytes with HA secretion was followed as described in Fig. S4.
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